메뉴 건너뛰기




Volumn 8, Issue 5, 2014, Pages 1575-1580

miR‑155 inhibitor reduces the proliferation and migration in osteosarcoma MG‑63 cells

Author keywords

Migration; miR 155 inhibitor; Osteosarcoma; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA 155; MICRORNA 155 INHIBITOR; UNCLASSIFIED DRUG;

EID: 84907808550     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1942     Document Type: Article
Times cited : (21)

References (45)
  • 3
    • 0026503028 scopus 로고
    • Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience
    • Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10: 5-15, 1992.
    • (1992) J Clin Oncol , vol.10 , pp. 5-15
    • Meyers, P.A.1    Heller, G.2    Healey, J.3
  • 4
    • 0038343499 scopus 로고    scopus 로고
    • MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
    • Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676, 2003.
    • (2003) Cell , vol.113 , pp. 673-676
    • Ambros, V.1
  • 5
    • 58249088751 scopus 로고    scopus 로고
    • MicroRNAs: Target recognition and regulatory functions
    • Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
    • (2009) Cell , vol.136 , pp. 215-233
    • Bartel, D.P.1
  • 6
    • 0037418839 scopus 로고    scopus 로고
    • Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila
    • Brennecke J, Hipfner DR, Stark A, Russell RB and Cohen SM: bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36, 2003.
    • (2003) Cell , vol.113 , pp. 25-36
    • Brennecke, J.1    Hipfner, D.R.2    Stark, A.3    Russell, R.B.4    Cohen, S.M.5
  • 7
    • 0034708122 scopus 로고    scopus 로고
    • The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
    • Reinhart BJ, Slack FJ, Basson M, et al: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906, 2000.
    • (2000) Nature , vol.403 , pp. 901-906
    • Reinhart, B.J.1    Slack, F.J.2    Basson, M.3
  • 9
    • 77958569998 scopus 로고    scopus 로고
    • Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: From functions to targets
    • Wang D, Qiu C, Zhang H, Wang J, Cui Q and Yin Y: Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One 5: e13067, 2010.
    • (2010) PLoS One , vol.5
    • Wang, D.1    Qiu, C.2    Zhang, H.3    Wang, J.4    Cui, Q.5    Yin, Y.6
  • 10
    • 33846188098 scopus 로고    scopus 로고
    • microRNAs as oncogenes and tumor suppressors
    • Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
    • (2007) Dev Biol , vol.302 , pp. 1-12
    • Zhang, B.1    Pan, X.2    Cobb, G.P.3    Anderson, T.A.4
  • 11
    • 27244432205 scopus 로고    scopus 로고
    • MicroRNAs as oncogenes and tumor suppressors
    • Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
    • (2005) N Engl J Med , vol.353 , pp. 1768-1771
    • Chen, C.Z.1
  • 12
    • 60149084560 scopus 로고    scopus 로고
    • MicroRNAs and cancer: Short RNAs go a long way
    • Ventura A and Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591, 2009.
    • (2009) Cell , vol.136 , pp. 586-591
    • Ventura, A.1    Jacks, T.2
  • 14
    • 84878404863 scopus 로고    scopus 로고
    • MicroRNAs in osteosarcoma: From biological players to clinical contributors, a review
    • Zhou G, Shi X, Zhang J, Wu S and Zhao J: MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review. J Int Med Res 41: 1-12, 2013.
    • (2013) J Int Med Res , vol.41 , pp. 1-12
    • Zhou, G.1    Shi, X.2    Zhang, J.3    Wu, S.4    Zhao, J.5
  • 15
    • 84880320805 scopus 로고    scopus 로고
    • Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling
    • Li Y, Zhang J, Zhang L, Si M, Yin H and Li J: Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis 34: 1601-1610, 2013.
    • (2013) Carcinogenesis , vol.34 , pp. 1601-1610
    • Li, Y.1    Zhang, J.2    Zhang, L.3    Si, M.4    Yin, H.5    Li, J.6
  • 16
    • 41749113108 scopus 로고    scopus 로고
    • MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
    • Asangani IA, Rasheed SA, Nikolova DA, et al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136, 2008.
    • (2008) Oncogene , vol.27 , pp. 2128-2136
    • Asangani, I.A.1    Rasheed, S.A.2    Nikolova, D.A.3
  • 17
    • 34547524771 scopus 로고    scopus 로고
    • MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
    • Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007.
    • (2007) Gastroenterology , vol.133 , pp. 647-658
    • Meng, F.1    Henson, R.2    Wehbe-Janek, H.3    Ghoshal, K.4    Jacob, S.T.5    Patel, T.6
  • 18
    • 84655165083 scopus 로고    scopus 로고
    • MicroRNA-21 is involved in osteosarcoma cell invasion and migration
    • Ziyan W, Shuhua Y, Xiufang W and Xiaoyun L: MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 28: 1469-1474, 2011.
    • (2011) Med Oncol , vol.28 , pp. 1469-1474
    • Ziyan, W.1    Shuhua, Y.2    Xiufang, W.3    Xiaoyun, L.4
  • 19
    • 84863719696 scopus 로고    scopus 로고
    • MicroRNA cloning and sequencing in osteosarcoma cell lines: Differential role of miR-93
    • Montanini L, Lasagna L, Barili V, et al: MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93. Cell Oncol (Dordr) 35: 29-41, 2012.
    • (2012) Cell Oncol (Dordr) , vol.35 , pp. 29-41
    • Montanini, L.1    Lasagna, L.2    Barili, V.3
  • 20
    • 84863121672 scopus 로고    scopus 로고
    • miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression
    • Huang G, Nishimoto K, Zhou Z, Hughes D and Kleinerman ES: miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 72: 908-916, 2012.
    • (2012) Cancer Res , vol.72 , pp. 908-916
    • Huang, G.1    Nishimoto, K.2    Zhou, Z.3    Hughes, D.4    Kleinerman, E.S.5
  • 21
    • 80051587553 scopus 로고    scopus 로고
    • MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration
    • Duan Z, Choy E, Harmon D, et al: MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 10: 1337-1345, 2011.
    • (2011) Mol Cancer Ther , vol.10 , pp. 1337-1345
    • Duan, Z.1    Choy, E.2    Harmon, D.3
  • 22
    • 83055163471 scopus 로고    scopus 로고
    • miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3
    • Liu LH, Li H, Li JP, et al: miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Biochem Biophys Res Commun 416: 31-38, 2011.
    • (2011) Biochem Biophys Res Commun , vol.416 , pp. 31-38
    • Liu, L.H.1    Li, H.2    Li, J.P.3
  • 23
    • 78149320174 scopus 로고    scopus 로고
    • microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2
    • Zhang H, Cai X, Wang Y, Tang H, Tong D and Ji F: microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24: 1363-1369, 2010.
    • (2010) Oncol Rep , vol.24 , pp. 1363-1369
    • Zhang, H.1    Cai, X.2    Wang, Y.3    Tang, H.4    Tong, D.5    Ji, F.6
  • 24
    • 80755184684 scopus 로고    scopus 로고
    • Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma
    • Thayanithy V, Sarver AL, Kartha RV, et al: Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone 50: 171-181, 2012.
    • (2012) Bone , vol.50 , pp. 171-181
    • Thayanithy, V.1    Sarver, A.L.2    Kartha, R.V.3
  • 25
    • 14844354250 scopus 로고    scopus 로고
    • Accumulation of miR-155 and BIC RNA in human B cell lymphomas
    • Eis PS, Tam W, Sun L, et al: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632, 2005.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 3627-3632
    • Eis, P.S.1    Tam, W.2    Sun, L.3
  • 26
    • 26044481464 scopus 로고    scopus 로고
    • BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
    • Kluiver J, Poppema S, de Jong D, et al: BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-249, 2005.
    • (2005) J Pathol , vol.207 , pp. 243-249
    • Kluiver, J.1    Poppema, S.2    de Jong, D.3
  • 27
    • 0031022801 scopus 로고    scopus 로고
    • Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: A report from the Children's Cancer Group
    • Provisor AJ, Ettinger LJ, Nachman JB, et al: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15: 76-84, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 76-84
    • Provisor, A.J.1    Ettinger, L.J.2    Nachman, J.B.3
  • 28
    • 0038518570 scopus 로고    scopus 로고
    • Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651
    • Goorin AM, Schwartzentruber DJ, Devidas M, et al; Pediatric Oncology Group: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21: 1574-1580, 2003.
    • (2003) J Clin Oncol , vol.21 , pp. 1574-1580
    • Goorin, A.M.1    Schwartzentruber, D.J.2    Devidas, M.3
  • 29
    • 84885900540 scopus 로고    scopus 로고
    • Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
    • Lauvrak SU, Munthe E, Kresse SH, et al: Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer 109: 2228-2236, 2013.
    • (2013) Br J Cancer , vol.109 , pp. 2228-2236
    • Lauvrak, S.U.1    Munthe, E.2    Kresse, S.H.3
  • 30
    • 0035710746 scopus 로고    scopus 로고
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
    • Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
    • (2001) Methods , vol.25 , pp. 402-408
    • Livak, K.J.1    Schmittgen, T.D.2
  • 33
    • 0027082303 scopus 로고
    • A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup
    • Bramwell VH, Burgers M, Sneath R, et al: A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 10: 1579-1591, 1992.
    • (1992) J Clin Oncol , vol.10 , pp. 1579-1591
    • Bramwell, V.H.1    Burgers, M.2    Sneath, R.3
  • 34
    • 0027381042 scopus 로고
    • Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin
    • Bacci G, Picci P, Ferrari S, et al: Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72: 3227-3238, 1993.
    • (1993) Cancer , vol.72 , pp. 3227-3238
    • Bacci, G.1    Picci, P.2    Ferrari, S.3
  • 35
    • 70349808172 scopus 로고    scopus 로고
    • Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel
    • Mora J, Cruz CO, Parareda A and de Torres C: Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel. J Pediatr Hematol Oncol 31: 723-729, 2009.
    • (2009) J Pediatr Hematol Oncol , vol.31 , pp. 723-729
    • Mora, J.1    Cruz, C.O.2    Parareda, A.3    de Torres, C.4
  • 36
    • 10844236347 scopus 로고    scopus 로고
    • A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma
    • McTiernan A and Whelan JS: A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma 8: 71-76, 2004.
    • (2004) Sarcoma , vol.8 , pp. 71-76
    • McTiernan, A.1    Whelan, J.S.2
  • 37
    • 48249154929 scopus 로고    scopus 로고
    • Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma
    • Navid F, Willert JR, McCarville MB, et al: Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer 113: 419-425, 2008.
    • (2008) Cancer , vol.113 , pp. 419-425
    • Navid, F.1    Willert, J.R.2    McCarville, M.B.3
  • 38
    • 0036847703 scopus 로고    scopus 로고
    • Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571
    • McGary EC, Weber K, Mills L, et al: Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 8: 3584-3591, 2002.
    • (2002) Clin Cancer Res , vol.8 , pp. 3584-3591
    • McGary, E.C.1    Weber, K.2    Mills, L.3
  • 39
    • 0037258254 scopus 로고    scopus 로고
    • Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma
    • Sulzbacher I, Birner P, Trieb K, Traxler M, Lang S and Chott A: Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma. Mod Pathol 16: 66-71, 2003.
    • (2003) Mod Pathol , vol.16 , pp. 66-71
    • Sulzbacher, I.1    Birner, P.2    Trieb, K.3    Traxler, M.4    Lang, S.5    Chott, A.6
  • 40
    • 43049095679 scopus 로고    scopus 로고
    • Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
    • Kubo T, Piperdi S, Rosenblum J, et al: Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Cancer 112: 2119-2129, 2008.
    • (2008) Cancer , vol.112 , pp. 2119-2129
    • Kubo, T.1    Piperdi, S.2    Rosenblum, J.3
  • 41
    • 18844467502 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
    • Kaya M, Wada T, Akatsuka T, et al: Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6: 572-577, 2000.
    • (2000) Clin Cancer Res , vol.6 , pp. 572-577
    • Kaya, M.1    Wada, T.2    Akatsuka, T.3
  • 42
    • 77953256426 scopus 로고    scopus 로고
    • R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts
    • Kolb EA, Kamara D, Zhang W, et al: R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts. Pediatr Blood Cancer 55: 67-75, 2010.
    • (2010) Pediatr Blood Cancer , vol.55 , pp. 67-75
    • Kolb, E.A.1    Kamara, D.2    Zhang, W.3
  • 43
    • 74549164751 scopus 로고    scopus 로고
    • NVP-BEZ235 as a new therapeutic option for sarcomas
    • Manara MC, Nicoletti G, Zambelli D, et al: NVP-BEZ235 as a new therapeutic option for sarcomas. Clin Cancer Res 16: 530-540, 2010.
    • (2010) Clin Cancer Res , vol.16 , pp. 530-540
    • Manara, M.C.1    Nicoletti, G.2    Zambelli, D.3
  • 44
    • 74549210540 scopus 로고    scopus 로고
    • Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
    • Pignochino Y, Grignani G, Cavalloni G, et al: Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways. Mol Cancer 8: 118, 2009.
    • (2009) Mol Cancer , vol.8 , pp. 118
    • Pignochino, Y.1    Grignani, G.2    Cavalloni, G.3
  • 45
    • 84866457087 scopus 로고    scopus 로고
    • The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression
    • Zhang W, Qian JX, Yi HL, et al: The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression. Mol Biol (Mosk) 46: 622-627, 2012.
    • (2012) Mol Biol (Mosk) , vol.46 , pp. 622-627
    • Zhang, W.1    Qian, J.X.2    Yi, H.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.